SARS-CoV-2 nucleocapsid antigen in urine of hospitalized patients with Covid-19
N Veyrenche, A Pisoni, S Debiesse, K Bollore, AS Bedin, A Makinson, C Niel, C Alcocer-Cordellat, AM Mondain, V Le Moing, P Van de Perre, E Tuaillon
doi: https://doi.org/10.1101/2021.09.28.21264239
N Veyrenche
1Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles; CHU Montpellier, Montpellier, France
A Pisoni
1Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles; CHU Montpellier, Montpellier, France
S Debiesse
2Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France
K Bollore
2Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France
AS Bedin
2Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles, Montpellier, France
A Makinson
3Tropical and Infectious Diseases, University Hospital, Montpellier, France. INSERM U1175/IRD UMI 233, IRD, Montpellier, France
C Niel
4Montpellier University Hospital, Montpellier, France
C Alcocer-Cordellat
4Montpellier University Hospital, Montpellier, France
AM Mondain
4Montpellier University Hospital, Montpellier, France
V Le Moing
3Tropical and Infectious Diseases, University Hospital, Montpellier, France. INSERM U1175/IRD UMI 233, IRD, Montpellier, France
P Van de Perre
1Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles; CHU Montpellier, Montpellier, France
E Tuaillon
1Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, University of Antilles; CHU Montpellier, Montpellier, France
Data Availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
Posted October 01, 2021.
SARS-CoV-2 nucleocapsid antigen in urine of hospitalized patients with Covid-19
N Veyrenche, A Pisoni, S Debiesse, K Bollore, AS Bedin, A Makinson, C Niel, C Alcocer-Cordellat, AM Mondain, V Le Moing, P Van de Perre, E Tuaillon
medRxiv 2021.09.28.21264239; doi: https://doi.org/10.1101/2021.09.28.21264239
SARS-CoV-2 nucleocapsid antigen in urine of hospitalized patients with Covid-19
N Veyrenche, A Pisoni, S Debiesse, K Bollore, AS Bedin, A Makinson, C Niel, C Alcocer-Cordellat, AM Mondain, V Le Moing, P Van de Perre, E Tuaillon
medRxiv 2021.09.28.21264239; doi: https://doi.org/10.1101/2021.09.28.21264239
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)